Literature DB >> 10969039

Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy.

S H Nelson1, O S Steinsland, Y Wang, C Yallampalli, Y L Dong, J M Sanchez.   

Abstract

Evidence exists that NO plays a role in the vasodilation that occurs during pregnancy. The purpose of the present study was to determine whether the role of NO is associated with an increase in the activity and protein expression of NO synthase (NOS) in the human uterine artery. Uterine arteries were obtained from pregnant patients (P arteries) and nonpregnant patients (NP arteries). NOS activity was estimated with the L-[(3)H]-arginine-to-L-[(3)H]-citrulline conversion method and on the basis of changes in tissue levels of cGMP. Western immunoblotting and immunohistochemistry were used to assess NOS protein expression. Ca(2+)-dependent NOS activity was 8 times greater (P:<0.01) in P than in NP arteries. Although most of this pregnancy-induced increase in NOS activity was Ca(2+) dependent (64%), a considerable portion was Ca(2+) independent. Expressions of endothelial NOS (eNOS) and neuronal NOS, but not inducible NOS, were demonstrated in P and NP arteries. The eNOS was located in the endothelium and stained with a qualitative order of P arteries>NP arteries (follicular)>NP arteries (luteal). The neuronal NOS was located in the adventitia of P and NP arteries. Basal NO-dependent and bradykinin-stimulated levels of cGMP were higher (P:<0.05) in P than in NP arteries. These results indicate that an upregulation of eNOS protein expression could account for the increased NO synthesis/release in the human uterine artery during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969039     DOI: 10.1161/01.res.87.5.406

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  51 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

3.  Assessment of uterine artery geometry and hemodynamics in human pregnancy with 4d flow mri and its correlation with doppler ultrasound.

Authors:  Eileen Hwuang; Marta Vidorreta; Nadav Schwartz; Brianna F Moon; Kirpal Kochar; Matthew Dylan Tisdall; John A Detre; Walter R T Witschey
Journal:  J Magn Reson Imaging       Date:  2018-11-03       Impact factor: 4.813

4.  Expression of kallikrein, bradykinin b2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta.

Authors:  Jenny Corthorn; Alfredo A Germain; Cecilia Chacón; Sergio Rey; Gloria X Soto; Carlos D Figueroa; Werner Müller-Esterl; Ignacio Duarte; Gloria Valdés
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

Review 5.  Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review.

Authors:  Vitaris Kodogo; Feriel Azibani; Karen Sliwa
Journal:  Clin Res Cardiol       Date:  2019-02-26       Impact factor: 5.460

6.  Venoarterial communication mediates arterial wall shear stress-induced maternal uterine vascular remodeling during pregnancy.

Authors:  Nga Ling Ko; Maurizio Mandalà; Liam John; Aaron Gelinne; George Osol
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

7.  Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction.

Authors:  Joanna L Stanley; Irene J Andersson; Cassandra J Hirt; Linn Moore; Mark R Dilworth; Alejandro R Chade; Colin P Sibley; Sandra T Davidge; Philip N Baker
Journal:  Biol Reprod       Date:  2012-07-26       Impact factor: 4.285

Review 8.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

9.  Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats.

Authors:  Jose Sergio Possomato-Vieira; Victor Hugo Gonçalves-Rizzi; Tamiris Uracs Sales Graça; Regina Aparecida Nascimento; Carlos A Dias-Junior
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-12       Impact factor: 3.000

Review 10.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.